{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:44:27Z","timestamp":1794278667456,"version":"4.9.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To compare pregnancy outcomes after laparoscopic radiofrequency ablation and myomectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The ULTRA (Uterine Leiomyoma Treatment With Radiofrequency Ablation) study is an ongoing multicenter prospective cohort study with longitudinal follow-up up to 5 years comparing outcomes of radiofrequency ablation with myomectomy in premenopausal women older than age 21 years with symptomatic uterine leiomyomas. Participants were queried every 6 months after surgery to assess the incidence of pregnancy and pregnancy outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>Among 539 women enrolled in ULTRA, a total of 37 participants (mean age at first pregnancy 35.0\u00b14.7 years) conceived 43 times as of March 2023 (22 radiofrequency ablation, 21 myomectomy). The average length of follow-up time after all procedures was 2.5\u00b11.0 years. The baseline miscarriage rate in the study population was 33.3%. In participants who underwent radiofrequency ablation, 9 of 22 pregnancies (40.9%, 95% CI, 20.3\u201361.5%) ended in first-trimester miscarriage, 11 resulted in live births (50.0%, 95% CI, 29.1\u201370.9%), one resulted fetal death at 30 weeks of gestation, and one resulted in uterine rupture during miscarriage treatment with misoprostol 10 weeks after radiofrequency ablation. Among the live births in the radiofrequency ablation group, 45.5% were by vaginal delivery. In the myomectomy group, 9 of 21 pregnancies (42.9%, 95% CI, 21.7\u201364.0%) ended in first-trimester miscarriage and 12 resulted in live births (57.1%, 95% CI, 36.0\u201378.3%). There were no significant differences in the likelihood of live birth or miscarriage between the study groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Full-term pregnancy and vaginal delivery are achievable after radiofrequency ablation of leiomyomas. However, in this interim analysis, the miscarriage rate in both radiofrequency ablation and myomectomy groups was higher than expected for women in this age group. Long-term data collection in the ongoing ULTRA study aims to further understand pregnancy outcomes after radiofrequency ablation compared with myomectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT0210094.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005548","type":"journal-article","created":{"date-parts":[[2024,2,29]],"date-time":"2024-02-29T17:02:25Z","timestamp":1709226145000},"page":"612-618","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":18,"title":["Pregnancy Outcomes After Laparoscopic Radiofrequency Ablation of Uterine Leiomyomas Compared With Myomectomy"],"prefix":"10.1097","volume":"143","author":[{"given":"Antoinette","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Schembri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram","family":"Parvataneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Elaine","family":"Waetjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Varon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naghmeh","family":"Salamat-Saberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn","family":"Tassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly A.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa L.","family":"Jacoby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,3,1]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ajog.2013.08.008","article-title":"The health disparities of uterine fibroid tumors for African American women: a public health issue","volume":"210","author":"Eltoukhi","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1067\/mob.2003.99","article-title":"High cumulative incidence of uterine leiomyoma in Black and White women: ultrasound evidence","volume":"188","author":"Baird","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R3-20250423","doi-asserted-by":"crossref","first-page":"492.e1","DOI":"10.1016\/j.ajog.2011.07.008","article-title":"Leiomyoma-related hospitalization and surgery: prevalence and predicted growth based on population trends","volume":"205","author":"Wechter","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"R4-20250423","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/GME.0000000000001043","article-title":"Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study","volume":"25","author":"Laughlin-Tommaso","year":"2018","journal-title":"Menopause"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2147\/CEOR.S155038","article-title":"Clinical outcomes and health care utilization pre- and post-laparoscopic radiofrequency ablation of symptomatic fibroids and laparoscopic myomectomy: a randomized trial of uterine-sparing techniques (TRUST) in Canada","volume":"10","author":"Rattray","year":"2018","journal-title":"Clinicoecon Outcomes Res"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/AOG.0b013e31828b7962","article-title":"Outpatient procedure for the treatment and relief of symptomatic uterine myomas","volume":"121","author":"Chudnoff","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1477-7525-11-139","article-title":"Radiofrequency volumetric thermal ablation of fibroids: a prospective, clinical analysis of two years' outcome from the Halt trial","volume":"11","author":"Guido","year":"2013","journal-title":"Health Qual Life Outcomes"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jmig.2022.01.009","article-title":"Clinical and patient reported outcomes of pre- and postsurgical treatment of symptomatic uterine leiomyomas: a 12-month follow-up review of TRUST, a surgical randomized clinical trial comparing laparoscopic radiofrequency ablation and myomectomy","volume":"29","author":"Yu","year":"2022","journal-title":"J Minim Invasive Gynecol"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1007\/s13669-016-0183-x","article-title":"Radiofrequency ablation of uterine fibroids: a review","volume":"5","author":"Lee","year":"2016","journal-title":"Curr Obstet Gynecol Rep"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.jeconom.2022.04.001","article-title":"Cluster-robust inference: a guide to empirical practice","volume":"232","author":"MacKinnon","year":"2023","journal-title":"J Econom"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jmig.2019.06.009","article-title":"Case series of reproductive outcomes after laparoscopic radiofrequency ablation of symptomatic myomas","volume":"27","author":"Berman","year":"2020","journal-title":"J Minim Invasive Gynecol"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/aje\/kwx062","article-title":"Prospective cohort study of uterine fibroids and miscarriage risk","volume":"186","author":"Hartmann","year":"2017","journal-title":"Am J Epidemiol"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1715726","article-title":"Mifepristone pretreatment for the medical management of early pregnancy loss","volume":"378","author":"Schreiber","year":"2018","journal-title":"N Engl J Med"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1471-0528.2005.00725.x","article-title":"WHO systematic review of maternal mortality and morbidity: the prevalence of uterine rupture","volume":"112","author":"Hofmeyr","year":"2005","journal-title":"BJOG"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1479-828X.2006.00673.x","article-title":"Misoprostol for termination of mid-trimester post-caesarean pregnancy","volume":"47","author":"Bhattacharjee","year":"2007","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.AOG.0000151996.16422.88","article-title":"Misoprostol for second-trimester pregnancy termination in women with a prior cesarean delivery","volume":"105","author":"Dickinson","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/j.1471-0528.2004.00285.x","article-title":"Misoprostol for second trimester pregnancy termination in women with prior caesarean section","volume":"112","author":"Daskalakis","year":"2005","journal-title":"BJOG"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005548","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T13:02:38Z","timestamp":1745413358000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005548"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,1]]},"references-count":17,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005548","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3,1]]},"assertion":[{"value":"2023-11-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-01-18","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}